Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2724351rdf:typepubmed:Citationlld:pubmed
pubmed-article:2724351lifeskim:mentionsumls-concept:C0012155lld:lifeskim
pubmed-article:2724351lifeskim:mentionsumls-concept:C1882810lld:lifeskim
pubmed-article:2724351lifeskim:mentionsumls-concept:C0015689lld:lifeskim
pubmed-article:2724351lifeskim:mentionsumls-concept:C0133860lld:lifeskim
pubmed-article:2724351lifeskim:mentionsumls-concept:C0221198lld:lifeskim
pubmed-article:2724351lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2724351lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:2724351pubmed:issue11lld:pubmed
pubmed-article:2724351pubmed:dateCreated1989-6-26lld:pubmed
pubmed-article:2724351pubmed:abstractTextWe examined the effect of varying the ratio of dietary omega-3 (omega 3) to omega-6 (omega 6) on the development of pancreatic preneoplastic lesions in male Wistar rats given azaserine at 14 days of age. As the ratio of dietary omega 3 to omega 6 fatty acids increased in a diet totaling 20% by weight of fat, the development of preneoplastic atypical acinar cell nodules (AACNs) at 4 months after dosing with azaserine decreased significantly. In addition, serum levels of prostaglandin thromboxane B2, prostaglandin E2, and 6-keto-prostaglandin F1 alpha decreased significantly. The fatty acid composition of the rbc membrane was also significantly influenced by the ratio of dietary omega 3 to omega 6 fatty acids. In a second experiment, we examined the effect of dietary intervention with a different type of fat (corn oil or menhaden oil) 2 months into the 4-month postdosing period on AACN development at the end of the post-dosing period. Intervention of the omega 6 fatty acid-rich diet with the omega 3 fatty acid-rich diet significantly decreased focal development. The opposite was true when intervention involved substituting the omega 3 fatty acid-rich diet with the omega 6 fatty acid-rich diet.lld:pubmed
pubmed-article:2724351pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2724351pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2724351pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2724351pubmed:languageenglld:pubmed
pubmed-article:2724351pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2724351pubmed:citationSubsetIMlld:pubmed
pubmed-article:2724351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2724351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2724351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2724351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2724351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2724351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2724351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2724351pubmed:statusMEDLINElld:pubmed
pubmed-article:2724351pubmed:monthJunlld:pubmed
pubmed-article:2724351pubmed:issn0027-8874lld:pubmed
pubmed-article:2724351pubmed:authorpubmed-author:CampbellT CTClld:pubmed
pubmed-article:2724351pubmed:authorpubmed-author:KinsellaJ EJElld:pubmed
pubmed-article:2724351pubmed:authorpubmed-author:PetersonF JFJlld:pubmed
pubmed-article:2724351pubmed:authorpubmed-author:RoebuckB DBDlld:pubmed
pubmed-article:2724351pubmed:authorpubmed-author:O'ConnorT PTPlld:pubmed
pubmed-article:2724351pubmed:authorpubmed-author:LokeshBBlld:pubmed
pubmed-article:2724351pubmed:issnTypePrintlld:pubmed
pubmed-article:2724351pubmed:day7lld:pubmed
pubmed-article:2724351pubmed:volume81lld:pubmed
pubmed-article:2724351pubmed:ownerNLMlld:pubmed
pubmed-article:2724351pubmed:authorsCompleteYlld:pubmed
pubmed-article:2724351pubmed:pagination858-63lld:pubmed
pubmed-article:2724351pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:meshHeadingpubmed-meshheading:2724351-...lld:pubmed
pubmed-article:2724351pubmed:year1989lld:pubmed
pubmed-article:2724351pubmed:articleTitleEffect of dietary omega-3 and omega-6 fatty acids on development of azaserine-induced preneoplastic lesions in rat pancreas.lld:pubmed
pubmed-article:2724351pubmed:affiliationDivision of Nutritional Sciences, Cornell University, Ithaca, NY.lld:pubmed
pubmed-article:2724351pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2724351pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2724351pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:2724351pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2724351lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2724351lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2724351lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2724351lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2724351lld:pubmed